Engi F Attia1, Kathleen A McGinnis, Laura C Feemster, Kathleen M Akgün, Adeel A Butt, Christopher J Graber, Michael J Fine, Matthew B Goetz, Maria C Rodriguez-Barradas, Margaret A Pisani, Hilary A Tindle, Sheldon T Brown, Guy W Soo Hoo, David Rimland, Cynthia L Gibert, Laurence Huang, Matthew S Freiberg, Catherine L Hough, Kristina Crothers. 1. *Department of Medicine, University of Washington, Seattle, WA; †Veterans Affairs Connecticut Healthcare System, West Haven, CT; ‡Veterans Affairs Health Services Research and Development, Veterans Affairs Puget Sound Healthcare System, Seattle, WA; §Department of Medicine, Veterans Affairs Connecticut Healthcare System, West Haven, CT, and Department of Medicine, Yale University School of Medicine, New Haven, CT; ‖Department of Medicine and Veterans Affairs Pittsburgh Healthcare System, University of Pittsburgh School of Medicine, Pittsburgh, PA, and Hamad Medical Corporation, Doha, Qatar; ¶Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System and David Geffen School of Medicine at UCLA, Los Angeles, CA; #Division of General Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA; **Infectious Diseases Section, Michael E. DeBakey Veterans Affairs Medical Center and Department of Medicine, Baylor College of Medicine, Houston, Texas; ††Department of Medicine, Yale University School of Medicine, New Haven, CT; ‡‡Department of Medicine, Vanderbilt University School of Medicine and Nashville Veterans Affairs Medical Center, Nashville, TN; §§James J. Peters Veterans Affairs Medical Center, Department of Medicine, Bronx and Department of Medicine, Icahn School of Medicine at Mt. Sinai, New York, NY; ‖‖Department of Medicine, Atlanta Veterans Affairs Medical Center and Emory University School of Medicine, Atlanta, GA; ¶¶Department of Medicine, Washington DC Veterans Affairs Medical Center and George Washington University School of Medicine, Washington, DC; and ##Department of Medicine, University of California San Francisco, San Francisco, CA.
Abstract
BACKGROUND: Pulmonary infections remain more common in HIV-infected (HIV+) compared with uninfected individuals. The increase in chronic lung diseases among aging HIV+ individuals may contribute to this persistent risk. We sought to determine whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for different pulmonary infections requiring hospitalization among HIV+ patients. METHODS: We analyzed data from 41,993 HIV+ Veterans in the nationwide Veterans Aging Cohort Study Virtual Cohort from 1996 to 2009. Using International Classification of Diseases, Ninth Revision codes, we identified baseline comorbid conditions, including COPD, and incident community-acquired pneumonia (CAP), pulmonary tuberculosis (TB), and Pneumocystis jirovecii pneumonia (PCP) requiring hospitalization within 2 years after baseline. We used multivariable Poisson regression to determine incidence rate ratios (IRRs) associated with COPD for each type of pulmonary infection, adjusting for comorbidities, CD4 cell count, HIV viral load, smoking status, substance use, vaccinations, and calendar year at baseline. RESULTS: Unadjusted incidence rates of CAP, TB, and PCP requiring hospitalization were significantly higher among persons with COPD compared to those without COPD (CAP: 53.9 vs. 19.4 per 1000 person-years; TB: 8.7 vs. 2.8; PCP: 15.5 vs. 9.2; P ≤ 0.001). In multivariable Poisson regression models, COPD was independently associated with increased risk of CAP, TB, and PCP (IRR: 1.94, 95% confidence interval [CI]: 1.64 to 2.30; IRR: 2.60, 95% CI: 1.70 to 3.97; and IRR: 1.48, 95% CI: 1.10 to 2.01, respectively). CONCLUSIONS: COPD is an independent risk factor for CAP, TB, and PCP requiring hospitalization among HIV+ individuals. As the HIV+ population ages, the growing burden of COPD may confer substantial risk for pulmonary infections.
BACKGROUND:Pulmonary infections remain more common in HIV-infected (HIV+) compared with uninfected individuals. The increase in chronic lung diseases among aging HIV+ individuals may contribute to this persistent risk. We sought to determine whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for different pulmonary infections requiring hospitalization among HIV+ patients. METHODS: We analyzed data from 41,993 HIV+ Veterans in the nationwide Veterans Aging Cohort Study Virtual Cohort from 1996 to 2009. Using International Classification of Diseases, Ninth Revision codes, we identified baseline comorbid conditions, including COPD, and incident community-acquired pneumonia (CAP), pulmonary tuberculosis (TB), and Pneumocystis jirovecii pneumonia (PCP) requiring hospitalization within 2 years after baseline. We used multivariable Poisson regression to determine incidence rate ratios (IRRs) associated with COPD for each type of pulmonary infection, adjusting for comorbidities, CD4 cell count, HIV viral load, smoking status, substance use, vaccinations, and calendar year at baseline. RESULTS: Unadjusted incidence rates of CAP, TB, and PCP requiring hospitalization were significantly higher among persons with COPD compared to those without COPD (CAP: 53.9 vs. 19.4 per 1000 person-years; TB: 8.7 vs. 2.8; PCP: 15.5 vs. 9.2; P ≤ 0.001). In multivariable Poisson regression models, COPD was independently associated with increased risk of CAP, TB, and PCP (IRR: 1.94, 95% confidence interval [CI]: 1.64 to 2.30; IRR: 2.60, 95% CI: 1.70 to 3.97; and IRR: 1.48, 95% CI: 1.10 to 2.01, respectively). CONCLUSIONS:COPD is an independent risk factor for CAP, TB, and PCP requiring hospitalization among HIV+ individuals. As the HIV+ population ages, the growing burden of COPD may confer substantial risk for pulmonary infections.
Authors: Amanda Mocroft; Peter Reiss; Ole Kirk; Cristina Mussini; Enrico Girardi; Philippe Morlat; Christoph Stephan; Stephane De Wit; Katja Doerholt; Jade Ghosn; Heiner C Bucher; Jens D Lundgren; Genevieve Chene; Jose M Miro; Hansjakob Furrer Journal: Clin Infect Dis Date: 2010-09-01 Impact factor: 9.079
Authors: Colette J Smith; Lene Ryom; Rainer Weber; Philippe Morlat; Christian Pradier; Peter Reiss; Justyna D Kowalska; Stephane de Wit; Matthew Law; Wafaa el Sadr; Ole Kirk; Nina Friis-Moller; Antonella d'Arminio Monforte; Andrew N Phillips; Caroline A Sabin; Jens D Lundgren Journal: Lancet Date: 2014-07-19 Impact factor: 79.321
Authors: Colin R Cooke; Min J Joo; Stephen M Anderson; Todd A Lee; Edmunds M Udris; Eric Johnson; David H Au Journal: BMC Health Serv Res Date: 2011-02-16 Impact factor: 2.655
Authors: M Bradley Drummond; Gregory D Kirk; Jacquie Astemborski; Meredith C McCormack; Mariah M Marshall; Shruti H Mehta; Robert A Wise; Christian A Merlo Journal: Int J Chron Obstruct Pulmon Dis Date: 2011-01-19
Authors: Joan Gómez-Junyent; Carolina Garcia-Vidal; Diego Viasus; Pere Millat-Martínez; Antonella Simonetti; Ma Salud Santos; Carmen Ardanuy; Jordi Dorca; Jordi Carratalà Journal: PLoS One Date: 2014-08-28 Impact factor: 3.240
Authors: Matthew Triplette; Amy Justice; Engi F Attia; Janet Tate; Sheldon T Brown; Matthew Bidwell Goetz; Joon W Kim; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Cherry Wongtrakool; Kathleen Akgün; Kristina Crothers Journal: AIDS Date: 2018-02-20 Impact factor: 4.177
Authors: Joyonna Carrie Gamble-George; Christopher T Longenecker; Allison R Webel; David H Au; Arleen F Brown; Hayden Bosworth; Kristina Crothers; William E Cunningham; Kevin A Fiscella; Alison B Hamilton; Christian D Helfrich; Joseph A Ladapo; Amneris Luque; Jonathan N Tobin; Gail E Wyatt Journal: Prog Cardiovasc Dis Date: 2020-03-19 Impact factor: 8.194
Authors: Yohhei Hamada; Christopher J Fong; Andrew Copas; John R Hurst; Molebogeng X Rangaka Journal: Trans R Soc Trop Med Hyg Date: 2022-05-02 Impact factor: 2.184
Authors: Thibaut Davy-Mendez; Sonia Napravnik; Brenna C Hogan; Keri N Althoff; Kelly A Gebo; Richard D Moore; Michael A Horberg; Michael J Silverberg; M John Gill; Heidi M Crane; Vincent C Marconi; Ronald J Bosch; Jonathan A Colasanti; Timothy R Sterling; W Christopher Mathews; Angel M Mayor; Ni Gusti Ayu Nanditha; Kate Buchacz; Jun Li; Peter F Rebeiro; Jennifer E Thorne; Ank Nijhawan; David van Duin; David A Wohl; Joseph J Eron; Stephen A Berry Journal: J Infect Dis Date: 2021-06-15 Impact factor: 5.226